![](/img/cover-not-exists.png)
The combination of gemcitabine and oxaliplatin (GEM-OXAL) is feasible in patients with poor prognosis advanced non-small cell lung cancer (NSCLC). Results of a phase II study
V. Franciosi, R. Barbieri, G. Vasini, E. Aitini, C. Cacciani, R. Capra, F. Greco, C. Bozzetti, S. CascinuVolume:
37
Year:
2001
Language:
english
DOI:
10.1016/s0959-8049(01)80692-4
File:
PDF, 182 KB
english, 2001